- Home
- WGSWW vs BPYPN Comparison
WGSWW vs BPYPN Comparison
Compare WGSWW & BPYPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- BPYPN
- Stock Information
- Founded
- WGSWW 2017
- BPYPN N/A
- Country
- WGSWW United States
- BPYPN Bermuda
- Employees
- WGSWW N/A
- BPYPN 30200
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- BPYPN Real Estate
- Sector
- WGSWW Technology
- BPYPN Finance
- Exchange
- WGSWW Nasdaq
- BPYPN Nasdaq
- Market Cap
- WGSWW N/A
- BPYPN N/A
- IPO Year
- WGSWW N/A
- BPYPN N/A
- Fundamental
- Price
- WGSWW $0.25
- BPYPN $14.19
- Analyst Decision
- WGSWW
- BPYPN
- Analyst Count
- WGSWW 0
- BPYPN 0
- Target Price
- WGSWW N/A
- BPYPN N/A
- AVG Volume (30 Days)
- WGSWW 35.4K
- BPYPN N/A
- Earning Date
- WGSWW 02-18-2025
- BPYPN N/A
- Dividend Yield
- WGSWW N/A
- BPYPN N/A
- EPS Growth
- WGSWW N/A
- BPYPN N/A
- EPS
- WGSWW N/A
- BPYPN N/A
- Revenue
- WGSWW $305,450,000.00
- BPYPN N/A
- Revenue This Year
- WGSWW N/A
- BPYPN N/A
- Revenue Next Year
- WGSWW N/A
- BPYPN N/A
- P/E Ratio
- WGSWW N/A
- BPYPN N/A
- Revenue Growth
- WGSWW 50.79
- BPYPN N/A
- 52 Week Low
- WGSWW $0.21
- BPYPN N/A
- 52 Week High
- WGSWW $0.25
- BPYPN N/A
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- BPYPN 58.58
- Support Level
- WGSWW N/A
- BPYPN $14.12
- Resistance Level
- WGSWW N/A
- BPYPN $14.55
- Average True Range (ATR)
- WGSWW 0.00
- BPYPN 0.15
- MACD
- WGSWW 0.00
- BPYPN -0.00
- Stochastic Oscillator
- WGSWW 0.00
- BPYPN 54.43
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
About BPYPN Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3
Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.